Literature DB >> 22762780

Acute calciphylaxis precipitated by the initiation of hemodialysis.

Gagangeet Sandhu, Pablo Casares, Aditi Ranade, James Jones, Levy I S Amar, Daniela Guisado, Germaine Chan, Steven D Smith.   

Abstract

Calciphylaxis, or calcific uremic arteriopathy (CUA), is characterized by metastatic calcification in the media of small arteries and arterioles leading to cutaneous necrosis. It is most commonly seen in patients with end stage renal disease who have elevated serum calcium × phosphorus (Ca × P) product. Normalization of Ca × P product is considered paramount in the prevention and treatment of CUA. We describe a novel presentation of CUA in which a Stage-5 CKD patient developed signs and symptoms of CUA immediately after initiation of hemodialysis (HD). We postulate that an influx of calcium from the dialysate into the patient's blood, in addition to correction of her acidosis, led to abundant substrate in a favorable milieu for Ca-P complex formation at the time of her first HD session. Our case is the first reported case of HD associated iatrogenic acute CUA. To avoid this complication, we should maintain adequate hydration,use lower calcium dialysate, and avoid vitamin D analogues and calcium-containing medications when initiating HD in patients with high Ca-P product. Since sodium thiosulfate is known to prevent precipitation of Ca-P complexes, its empiric use during initial HD treatments may be effective in preventing CUA, a potentially fatal disease.

Entities:  

Mesh:

Year:  2013        PMID: 22762780     DOI: 10.5414/CN107524

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  2 in total

1.  Penile and generalised calciphylaxis in peritoneal dialysis.

Authors:  Edmond Sarkis
Journal:  BMJ Case Rep       Date:  2015-04-16

2.  New-onset acute rapidly deteriorating case of calciphylaxis after open heart surgery: a case report.

Authors:  Mohammad El Diasty; Jose Cuenca
Journal:  Eur Heart J Case Rep       Date:  2021-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.